Delivery Order SPE2DB20D2104-SPE2DB24FR74X
Award Date 12/20/23
Potential Completion Date 12/21/23
Potential Value $1.5K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,330.20 firm fixed-price delivery order is for the supply of 4,564,118,694 units of the generic drug Bupropion HCl 100 mg tablets. The contract has an ultimate completion date of April 1, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award is for the delivery of Bupropion HCL XL 300 mg tablets to the Defense Logistics Agency (DLA). The $12,760.48 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of February 1, 2024 and was not set aside for any specific business category. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the U.S. Department of Defense's Medical Supply Chain agency to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Bupropion HCL XL 300 mg tablets. The firm-fixed-price delivery order, valued at $44,120.07, has an ultimate completion date of April 23, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 4,564,543,508 units of Bupropion HCL XL 300 mg tablets. The contract has a ceiling value of $13,933.62 and is a firm fixed-price delivery order that will run through May 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through...
- This federal contract award, with ID SPE2DB20D3103|SPE2DB24FN8K8, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,280.00 firm fixed-price delivery order is for 4564616990 - Bupropion HCL XL 150 mg tablets, with a completion date of May 16, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $13,605.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. Amerisourcebergen, a major pharmaceutical distribution company, was awarded this firm-fixed-price delivery order for the supply of 4,564,542,994 units of Bupropion HCl XL 300 mg tablets. The award does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, with ID SPE2DB22D3016|SPE2DB24FANG1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $18,343.07 firm-fixed-price delivery order is for the supply of 4563774938 - Bupropion HCl XL 300 mg Tablets, 500 count. The contract has an ultimate completion date of February 27, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,487.12 firm fixed-price delivery order is for the supply of 4,567,379,185 units of Bupropion HCL XL 300 mg tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, is a delivery order for Bupropion HCL XL 150 mg tablets worth $8,900.78. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $63,780.64, for the supply of 4564416340 - Bupropion HCL XL 300 MG Tablets in quantities of 500s. The contract has an ultimate completion date of April 29, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...